BE844544A - Insert ophtalmique pour le traitement du syndrome de l'oeil sec - Google Patents

Insert ophtalmique pour le traitement du syndrome de l'oeil sec

Info

Publication number
BE844544A
BE844544A BE169261A BE169261A BE844544A BE 844544 A BE844544 A BE 844544A BE 169261 A BE169261 A BE 169261A BE 169261 A BE169261 A BE 169261A BE 844544 A BE844544 A BE 844544A
Authority
BE
Belgium
Prior art keywords
treatment
dry eye
eye syndrome
ophthalmic insert
ophthalmic
Prior art date
Application number
BE169261A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE844544A publication Critical patent/BE844544A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE169261A 1975-07-29 1976-07-27 Insert ophtalmique pour le traitement du syndrome de l'oeil sec BE844544A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60016875A 1975-07-29 1975-07-29

Publications (1)

Publication Number Publication Date
BE844544A true BE844544A (fr) 1977-01-27

Family

ID=24402570

Family Applications (1)

Application Number Title Priority Date Filing Date
BE169261A BE844544A (fr) 1975-07-29 1976-07-27 Insert ophtalmique pour le traitement du syndrome de l'oeil sec

Country Status (16)

Country Link
US (1) US4343787A (fr)
JP (1) JPS5215811A (fr)
AU (1) AU509140B2 (fr)
BE (1) BE844544A (fr)
BR (1) BR7604876A (fr)
CH (1) CH631891A5 (fr)
CY (1) CY1137A (fr)
DE (1) DE2633988C2 (fr)
ES (3) ES450002A1 (fr)
FR (1) FR2319375A1 (fr)
GB (1) GB1543189A (fr)
HK (1) HK282A (fr)
IT (1) IT1062653B (fr)
NL (1) NL188266C (fr)
PT (1) PT65389B (fr)
SE (1) SE431508B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54145207A (en) * 1978-04-30 1979-11-13 Agency Of Ind Science & Technol High viscosity eye lotion
US4436730A (en) 1979-06-25 1984-03-13 Polymer Technology Corporation Ionic opthalmic cellulose polymer solutions
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
FI831399A7 (fi) * 1982-04-29 1983-10-30 Agripat Sa Karkaistua polyvinyylialkoholia oleva piilolinssi
EP0108661A1 (fr) * 1982-10-04 1984-05-16 Merck & Co. Inc. Insertions oculaires en hydroxypropyl cellulose stabilisées et procédé de stérilisation
US4565198A (en) * 1983-12-27 1986-01-21 Barnes-Hind, Inc. Method for altering the curvature of the cornea
US4660546A (en) * 1984-11-07 1987-04-28 Robert S. Herrick Method for treating for deficiency of tears
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4883658A (en) * 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US5229128A (en) * 1986-06-11 1993-07-20 Haddad Heskel M Drug delivery ophthalmic insert and method of preparing same
GB8623661D0 (en) * 1986-10-02 1986-11-05 Darougar S Ocular insert
US5989579A (en) * 1986-10-02 1999-11-23 Escalon Medical Corp. Ocular insert with anchoring protrusions
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
CA1317226C (fr) * 1987-05-04 1993-05-04 Phillip E. Pennell Liquide visco-elastique pour chirurgie ophtalmique et methode d'utilisation
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
GB8917216D0 (en) * 1989-07-27 1989-09-13 Smith & Nephew Ophthalmic composition
FR2688694B1 (fr) * 1992-03-20 1999-06-25 Vetoquinol Sa Insert ophtalmique bioadhesif.
MY113268A (en) 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
DE69432188T2 (de) 1993-04-30 2004-01-22 Nestle S.A. Synthetisches Viskoseelastisches Material für physiologische Anwendungen wie für Ophtalmologische Anwendungen
US5631004A (en) * 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
TW274516B (fr) * 1993-11-12 1996-04-21 Ciba Geigy Ag
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US5472436A (en) * 1994-07-26 1995-12-05 Fremstad; Daria A. Ocular appliance for delivering medication
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
DE19549506C2 (de) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Darreichungsform zur äußerlichen Applikation und Verfahren zur Herstellung derselben
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
US6193991B1 (en) * 1997-10-29 2001-02-27 Atul J. Shukla Biodegradable delivery systems of biologically active substances
JP2002538124A (ja) 1999-03-01 2002-11-12 ヴィスタ サイエンティフィック エルエルシー ムチンを含む眼科用調合物
US6264971B1 (en) 1999-11-04 2001-07-24 Btg International Limited Ocular insert
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US6613355B2 (en) 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
CN1283215C (zh) * 2000-06-28 2006-11-08 A·J·舒克拉 生物活性物质的可生物降解载体和释放系统
US7404825B2 (en) * 2001-06-11 2008-07-29 Herrick Ii Robert S Implant capable of forming a differential image in an eye
JP4677538B2 (ja) 2001-06-12 2011-04-27 ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン 眼内薬物送達のためのリザーバデバイス
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
CN100469776C (zh) * 2002-05-17 2009-03-18 奥特拉控股公司 白内障和其它眼病发展的改善
WO2004028536A1 (fr) * 2002-09-30 2004-04-08 Babizhayev Mark A Methode de traitement topique de maladies de l'oeil, composition et dispositif conçus pour ce traitement
DE10246900A1 (de) 2002-10-08 2004-04-22 Horstmann, Michael, Dr. Am Auge applizierbare Vorrichtung zur sicheren Dosierung systemischer und tropischer Medikation
US7825134B2 (en) * 2003-05-19 2010-11-02 Othera Holding, Inc. Amelioration of cataracts, macular degeneration and other ophthalmic diseases
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2527712C (fr) * 2003-06-13 2014-08-05 Alcon, Inc. Compositions ophtalmologiques contenant une association synergique de deux polymeres
CA2536185C (fr) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Systeme d'administration de produit pharmaceutique pour administrer des fins grains sous la capsule de tenon
JP4869930B2 (ja) 2003-08-26 2012-02-08 ヴィスタ サイエンティフィック エルエルシー 眼科薬物供給装置
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
US20060068012A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
US20060067978A1 (en) * 2004-09-29 2006-03-30 Bausch & Lomb Incorporated Process for preparing poly(vinyl alcohol) drug delivery devices
WO2007013590A1 (fr) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. Système non invasif d'administration de médicament qui vise le tissu postérieur de l'œil au moyen d’une composition solide
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
WO2008100807A2 (fr) * 2007-02-09 2008-08-21 Alcon, Inc. Compositions ophtalmiques comprenant une combinaison synergique de trois polymères
WO2008103613A2 (fr) 2007-02-22 2008-08-28 Othera Holding, Inc. Composés d'hydroxylamine et leurs procédés d'utilisation
JP2012512163A (ja) * 2008-12-11 2012-05-31 エーピー ファーマ， インコーポレイテッド ポリオルトエステルおよびそれらの製剤の安定性を高めるための方法
CA3045436C (fr) 2009-01-29 2025-10-07 Forsight Vision4, Inc. Administration d'un medicament dans le segment posterieur
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
WO2010101758A1 (fr) * 2009-03-03 2010-09-10 Alcon Research, Ltd. Dispositif péricornéen d'administration de médicaments
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
CA2776748A1 (fr) * 2009-10-08 2011-04-14 Neurotech Usa, Inc. Utilisation du pedf dans un systeme d'administration a base de cellules encapsulees
WO2011094170A1 (fr) * 2010-01-27 2011-08-04 Alcon Research, Ltd. Dispositif d'administration de médicaments péricornéens par intermittence
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
EP2585057B1 (fr) 2010-06-25 2017-08-23 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Méthode de traitement en utilisant acide sterculique
SG187231A1 (en) 2010-07-29 2013-02-28 Eleven Biotherapeutics Inc Chimeric il-1 receptor type i agonists and antagonists
CN103209664A (zh) 2010-08-05 2013-07-17 弗赛特影像4股份有限公司 可植入的治疗装置
CN103153316B (zh) 2010-08-05 2015-08-19 弗赛特影像4股份有限公司 组合药物递送方法和设备
WO2012019136A2 (fr) 2010-08-05 2012-02-09 Forsight Vision 4, Inc. Appareil d'injection et procédé d'administration de médicament
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP2726016B1 (fr) 2011-06-28 2023-07-19 ForSight Vision4, Inc. Un appareil pour collecter un échantillon de fluide à partir d'une chambre réservoir d'un dispositif thérapeutique pour l'oeil
US9102105B2 (en) 2011-09-13 2015-08-11 Vista Scientific Llc Method for forming an ocular drug delivery device
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
SI2755600T1 (sl) 2011-09-16 2021-08-31 Forsight Vision4, Inc. Naprava za izmenjavo tekočine
EP2911623B1 (fr) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Système ophtalmique pour la libération prolongée de médicament dans l' oeil
CN107693781B (zh) 2013-03-13 2021-11-09 巴扎德制药公司 用于眼部递送的嵌合细胞因子制剂
AU2014236455B2 (en) 2013-03-14 2018-07-12 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
AU2014241163B2 (en) 2013-03-28 2018-09-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
MY182793A (en) 2014-08-08 2021-02-05 Forsight Vision4 Inc Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
JP7037360B2 (ja) 2014-11-10 2022-03-16 フォーサイト・ビジョン フォー・インコーポレーテッド 拡張可能な薬物送達デバイス
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
KR20180084104A (ko) 2015-11-20 2018-07-24 포사이트 비젼4, 인크. 연장 방출 약물 전달 장치를 위한 다공성 구조물
BR112018070383A2 (pt) 2016-04-05 2019-02-05 Forsight Vision4 Inc dispositivos para aplicação de fármaco oculares implantáveis
CN115607358A (zh) 2017-11-21 2023-01-17 弗赛特影像4股份有限公司 用于可扩展端口递送系统的流体交换装置及使用方法
AU2020371620A1 (en) 2019-10-24 2022-03-31 Denis E. Labombard Ocular device and drug delivery system, with case
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
EP4518836A1 (fr) 2022-05-06 2025-03-12 Eyed Pharma Insert pour le traitement des yeux secs
BE1030503B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert pour le traitement de la sécheresse oculaire
BE1030504B1 (fr) 2022-05-06 2023-12-04 Eyed Pharma Insert composite pour le traitement de la sécheresse oculaire
WO2026087362A1 (fr) * 2024-10-21 2026-04-30 Consejo Superior De Investigaciones Científicas (Csic) Insert oculaire destiné à être utilisé dans le traitement de l'œil sec

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3767788A (en) * 1970-06-08 1973-10-23 Burton Parsons Chemicals Inc Ophthalmic solution
SE352811B (fr) * 1971-06-04 1973-01-15 Pharmacia Ab
US3845201A (en) * 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method
SE375007B (fr) * 1972-11-30 1975-04-07 Pharmacia Ab
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same
US3911098A (en) * 1974-02-11 1975-10-07 American Cyanamid Co Medicament carrier

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826871A (en) * 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4966773A (en) * 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles

Also Published As

Publication number Publication date
FR2319375A1 (fr) 1977-02-25
IT1062653B (it) 1984-10-20
GB1543189A (en) 1979-03-28
NL7607704A (nl) 1977-02-01
HK282A (en) 1982-01-15
FR2319375B1 (fr) 1982-07-23
US4343787A (en) 1982-08-10
DE2633988A1 (de) 1977-02-10
NL188266C (nl) 1992-05-18
BR7604876A (pt) 1977-08-09
PT65389A (en) 1976-08-01
ES461216A1 (es) 1978-05-01
NL188266B (nl) 1991-12-16
AU1607776A (en) 1978-01-26
SE431508B (sv) 1984-02-13
ES450002A1 (es) 1977-11-16
CH631891A5 (en) 1982-09-15
ES461217A1 (es) 1978-05-01
SE7608036L (sv) 1977-01-30
DE2633988C2 (de) 1986-09-11
CY1137A (en) 1982-05-07
PT65389B (en) 1978-06-09
JPS5215811A (en) 1977-02-05
JPS6122975B2 (fr) 1986-06-03
AU509140B2 (en) 1980-04-24

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
FR2508798B1 (fr) Derives anthraquinoniques pour le traitement des arthrites
FR2311818A1 (fr) Composition et procede pour le traitement de fibres keratiniques
BE843359A (fr) Preparation pour le traitement de parodontose
FR2340122A1 (fr) Composition anti-moussage pour le traitement de denrees alimentaires
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
IT8267795A0 (it) Composizione per trattamento del glaucoma
FR2307909A1 (fr) Compositions pour le traitement des etoffes
BE855633A (fr) Composition et procede pour le traitement de fibres
FR2306710A1 (fr) Composition pour le traitement du colon
BE851775A (fr) Composition pour le traitement de la chevelure
BE878590A (fr) Agents anti-adherence pour le traitement du soufre
FR2321576A1 (fr) Tampon pour l'obturation des trous d'extremite des dalles creuses
BE873092A (fr) Composition pour le traitement de l'hypertension
IT8267796A0 (it) Composizione per trattamento del glaucoma
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
FR2300547A1 (fr) Agents pour le traitement des cheveux
BE858692A (fr) Composition pour le traitement de l'acne
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
BE856740A (fr) Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
IT8267794A0 (it) Composizione per trattamento del glaucoma

Legal Events

Date Code Title Description
CCPA Application for a supplementary protection certificate

Free format text: 093C0154

CCPV Grant of a supplementary protection certificate

Free format text: 093C0154, EXPIRES 20010727

RE20 Patent expired

Owner name: MERCK & CO. INC.

Effective date: 19960727